OVAT.F Stock Overview

Engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States. More details

OVAT.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Earnings have grown 3.6% per year over the past 5 years

Risk Analysis

Shares are highly illiquid

Makes less than USD$1m in revenue (CA$112K)

Has less than 1 year of cash runway

Negative shareholders equity

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

Ovation Science Inc. Competitors

Kaya Holdings

OTCPK:KAYS

US$1.4m

Universe Pharmaceuticals

NasdaqCM:UPC

US$1.3m

Mallinckrodt

OTCPK:MNKT.Q

US$936.0k

Panacea Life Sciences Holdings

OTCPK:PLSH

US$1.2m

Price History & Performance

Summary of share price highs, lows and changes for Ovation Science
Historical stock prices
Current Share Price	CA$0.016
52 Week High	CA$0.044
52 Week Low	CA$0.01
Beta	-0.030
1 Month Change	56.44%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-73.27%
5 Year Change	-91.76%
Change since IPO	-94.39%

Recent updates

Shareholder Returns

	OVAT.F	US Pharmaceuticals	US Market
7D	-60.5%	0.4%	-2.1%
1Y	n/a	2.2%	21.3%

Return vs Industry: Insufficient data to determine how OVAT.F performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how OVAT.F performed against the US Market.

Price Volatility

Is OVAT.F's price volatile compared to industry and market?
OVAT.F volatility
OVAT.F Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	11.0%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.8%
10% least volatile stocks in US Market	3.2%

Stable Share Price: OVAT.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine OVAT.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2017	n/a	Terry Howlett	ovationscience.com

Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States. The company sublicenses product formulations through Invisicare, a patented drug delivery technology to produce topical and transdermal cannabis products under the Ovation name. It also offers cannabidiol health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil.

Ovation Science Inc. Fundamentals Summary

How do Ovation Science's earnings and revenue compare to its market cap?
OVAT.F fundamental statistics
Market cap	US$977.06k
Earnings (TTM)	-US$444.31k
Revenue (TTM)	US$77.59k

12.6x

P/S Ratio

-2.2x

P/E Ratio

Is OVAT.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OVAT.F income statement (TTM)
Revenue	CA$111.95k
Cost of Revenue	CA$40.02k
Gross Profit	CA$71.93k
Other Expenses	CA$713.01k
Earnings	-CA$641.09k

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.018
Gross Margin	64.25%
Net Profit Margin	-572.67%
Debt/Equity Ratio	-25.9%

How did OVAT.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/11 11:34
End of Day Share Price	2025/01/08 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ovation Science Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution